07
Jan

Isis Pharmaceuticals is shifting its cardiovascular pipeline into a new subsidiary, cutting the ribbon on Akcea Therapeutics and appointing former Genzyme executive Paula Soteropoulos to lead the way.

…read more

Source: Isis launches a cardio subsidiary and recruits a Genzyme vet to run it

    

0 No comments